# To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms

> **NCT02207400** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 246 (actual)

## Conditions studied

- Oral Hygiene

## Interventions

- **DRUG:** Sodium bicarbonate and sodium fluoride
- **DRUG:** Sodium fluoride

## Key facts

- **NCT ID:** NCT02207400
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-25
- **Primary completion:** 2015-02-01
- **Final completion:** 2015-04-30
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207400, "To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02207400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*